Your browser doesn't support javascript.
loading
The cumulative effects and clinical safety of repeat magnetic resonance imaging on an MRI-conditional pacemaker system at 1.5 tesla.
Nguyen, Thuy D; Sandberg, Sarah A; Durrani, Amir K; Mitchell, Kevin W; Keith, Matthew D; Gleva, Marye J; Woodard, Pamela K.
Afiliação
  • Nguyen TD; Divisions of Cardiovascular Medicine and Mallinckrodt Institute of Radiology, Washington University, Saint Louis, Missouri.
  • Sandberg SA; Divisions of Cardiovascular Medicine and Mallinckrodt Institute of Radiology, Washington University, Saint Louis, Missouri.
  • Durrani AK; Brookwood Baptist Health, Birmingham, Alabama.
  • Mitchell KW; Divisions of Cardiovascular Medicine and Mallinckrodt Institute of Radiology, Washington University, Saint Louis, Missouri.
  • Keith MD; Division of Cardiovascular Medicine, Washington Permanente, Seattle, Washington.
  • Gleva MJ; Clinical Studies Division at Biotronik, Inc, Lake Oswego, Oregon.
  • Woodard PK; Clinical Studies Division at Biotronik, Inc, Lake Oswego, Oregon.
Heart Rhythm O2 ; 2(1): 73-79, 2021 Feb.
Article em En | MEDLINE | ID: mdl-34113907
ABSTRACT

BACKGROUND:

Studies have demonstrated magnetic resonance imaging (MRI) safety in the presence of MRI-conditional permanent pacemakers (PPM). However, since patients' care may require serial MRIs, it is necessary to evaluate device safety and performance after multiple scans.

OBJECTIVES:

We evaluated safety and performance of MRI-conditional PPMs after serial MRIs over various anatomic regions performed during a multicenter, prospective, single-arm study (ProMRI).

METHODS:

ProMRI was a multiphase observational study designed to evaluate PPM performance after MRI scans. Our study evaluated PPM function in a cohort of patients who underwent multiple 1.5-T MRI scans. Selected patients underwent separate head, chest, and lumbar spine MRIs. Pacing capture threshold (PCT), lead impedance (LI), sensing amplitude, and battery capacity were collected before and after scanning. Freedom from serious adverse device effects (SADE) through 1 month post MRI served as a primary endpoint. Changes in PPM function parameters, including threshold success rate and sensing attenuation, were analyzed for statistical significance and clinical relevance.

RESULTS:

In 81 patients no adverse events or SADE occurred. Statistically significant changes in ventricular PCT (0.034 ± 0.15 V) immediately after, ventricular LI immediately after (-18.7 ± 44.2 Ω) and 1 month post phase B (-19.8 ± 44.9 Ω), and atrial sensing attenuation immediately after (-0.27 ± 0.92 mV) and 1 month post phase B (-0.22 ± 0.92 mV) were noted. However, these changes were not clinically relevant in degree.

CONCLUSION:

These results demonstrate the safety and performance of the ProMRI PPM in patients undergoing 3 serial MRIs over various anatomic regions.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article